Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;18(4):350-2.
doi: 10.1634/theoncologist.2012-0387. Epub 2013 Apr 10.

Screening for breast cancer-related lymphedema: the need for standardization

Jean O'Toole  1 , Lauren S Jammallo, Cynthia L Miller, Melissa N Skolny, Michelle C Specht, Alphonse G Taghian
Affiliations

Screening for breast cancer-related lymphedema: the need for standardization

Jean O'Toole et al. Oncologist. 2013.

Abstract

This commentary explores the challenges surrounding the development of a standard definition of lymphedema and method of quantification, proposes solutions, and calls for a collaborative effort among providers who care for patients with breast cancer.

PubMed Disclaimer

Conflict of interest statement

Disclosures of potential conflicts of interest may be found at the end of this article.

Figures

Figure 1.
Figure 1.
This woman's right arm is 54% larger than her left, demonstrating the physical distortion of a limb with advanced lymphedema.
Figure 2.
Figure 2.
The left arm of this woman is 9% larger than the right and is symptomatic, illustrating a low-level swelling that is an impairment.
Figure 3.
Figure 3.
The lymphedema screening trial being conducted at Massachusetts General Hospital involves preoperative perometer measurements and completion of a symptom, function, and quality-of-life questionnaire. Screening continues postoperatively, at the completion of chemotherapy and/or radiation therapy, and every 3–8 months thereafter. Abbreviations: CT, chemotherapy; RT, radiation therapy.
See this image and copyright information in PMC

References

    1. Bernas MJ, Askew RL, Armer JM, Cormier JN. Lymphedema: How do we diagnose and reduce the risk of this dreaded complication of breast cancer treatment? Curr Breast Cancer Rep. 2010;2:53–58.
    1. Armer JM, Stewart BR. Post-breast cancer lymphedema: Incidence increases from 12 to 30 to 60 months. Lymphology. 2010;43:118–127. - PMC - PubMed
    1. Hayes S, Janda M, Cornish B, et al. Lymphedema secondary to breast cancer: How choice of measure influences diagnosis, prevalence, and identifiable risk factors. Lymphology. 2008;41:18–28. - PubMed
    1. Stout NL, Pfalzer LA, Springer B, et al. Breast cancer-related lymphedema: Comparing direct costs of a prospective surveillance model and a traditional model of care. Phys Ther. 2012;92:152–163. - PMC - PubMed
    1. Shih YC, Xu Y, Cormier JN, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: A 2-year follow-up study. J Clin Oncol. 2009;27:2007–2014. - PubMed